|
Volumn 451, Issue 6, 2007, Pages 1091-1093
|
Small intestinal CD4+ T-cell lymphoma: A rare distinctive clinicopathological entity associated with prolonged survival [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISONE;
VINDESINE;
CANCER CHEMOTHERAPY;
CD4+ T LYMPHOCYTE;
CELIAC DISEASE;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE ASSOCIATION;
ENTEROPATHY;
EOSINOPHIL COUNT;
HISTOLOGY;
HOSPITAL ADMISSION;
HUMAN;
LETTER;
PRIORITY JOURNAL;
PROGNOSIS;
SMALL INTESTINE;
SURVIVAL RATE;
T CELL LYMPHOMA;
ADULT;
ANTIGENS, CD;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CD4-POSITIVE T-LYMPHOCYTES;
CHEMOTHERAPY, ADJUVANT;
DISEASE-FREE SURVIVAL;
HUMANS;
ILEAL NEOPLASMS;
ILEUM;
LYMPHOMA, T-CELL, PERIPHERAL;
MALE;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 36448979575
PISSN: 09456317
EISSN: None
Source Type: Journal
DOI: 10.1007/s00428-007-0475-7 Document Type: Letter |
Times cited : (33)
|
References (6)
|